Home › Leucemia linfoblastica acuta › California › Baldwin Park
Studi clinici su Leucemia linfoblastica acuta a Baldwin Park, CA
21 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi a Baldwin Park e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
In reclutamentoFase 2
- City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte · a 4 mi di distanza
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
In reclutamentoFase 1Volontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
In reclutamentoFase 1/2
- Research Site, Duarte · a 4 mi di distanza
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- City of Hope, Duarte · a 4 mi di distanza
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Study of Revumenib and Mezigdomide in People With Leukemia
In reclutamentoFase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · a 4 mi di distanza
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
In reclutamentoStudio osservazionale
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
In reclutamentoFase 3
- Ascentage Investigative Site #1062, Duarte · a 4 mi di distanza
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
In reclutamentoFase 1Volontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
In reclutamentoFase 1 iniziale
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
In reclutamentoFase 2Volontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
Studi su Leucemia linfoblastica acuta in altre città
- Houston, TX28 studi
- New York City, NY24 studi
- Seattle, WA21 studi
- Chicago, IL19 studi
- Atlanta, GA19 studi
- Philadelphia, PA16 studi
- Memphis, TN16 studi
- Washington, DC16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Durham, NC13 studi
- Mountain View, CA13 studi
Altri studi a Baldwin Park
- Cancro al seno45 studi
- Leucemia mieloide acuta40 studi
- Cancro colorettale38 studi
- Cancro del polmone non a piccole cellule36 studi
- Cancro (tutti i tipi)33 studi
- Cancro alla prostata30 studi
- Cancro metastatico30 studi
- Sindromi mielodisplastiche26 studi
- Cancro ovarico25 studi
- Cancro ai polmoni24 studi
- Mieloma multiplo23 studi
- Cancro dello stomaco22 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.